182 related articles for article (PubMed ID: 20100452)
21. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
[TBL] [Abstract][Full Text] [Related]
22. Gln(84) of moloney murine leukemia virus reverse transcriptase regulates the incorporation rates of ribonucleotides and deoxyribonucleotides.
Liu S; Goff SP; Gao G
FEBS Lett; 2006 Feb; 580(5):1497-501. PubMed ID: 16466720
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K
Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458
[TBL] [Abstract][Full Text] [Related]
24. Study of MMLV RT- binding with DNA using surface plasmon resonance biosensor.
Wu L; Huang MH; Zhao JL; Yang MS
Acta Biochim Biophys Sin (Shanghai); 2005 Sep; 37(9):634-42. PubMed ID: 16143819
[TBL] [Abstract][Full Text] [Related]
25. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
[TBL] [Abstract][Full Text] [Related]
26. RNA-binding and viral reverse transcriptase inhibitory activity of a novel cationic diamino acid-based peptide.
Roviello GN; Di Gaetano S; Capasso D; Franco S; Crescenzo C; Bucci EM; Pedone C
J Med Chem; 2011 Apr; 54(7):2095-101. PubMed ID: 21391685
[TBL] [Abstract][Full Text] [Related]
27. Incorporation of (alpha-P-borano)-2',3'-dideoxycytidine 5'-triphosphate into DNA by drug-resistant MMLV reverse transcriptase and Taq DNA polymerase.
Dobrikov MI; Sergueeva ZA; Shaw BR
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1651-5. PubMed ID: 14565487
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, spectroscopic studies and biological activity of a novel nucleopeptide with Moloney murine leukemia virus reverse transcriptase inhibitory activity.
Roviello GN; Di Gaetano S; Capasso D; Cesarani A; Bucci EM; Pedone C
Amino Acids; 2010 May; 38(5):1489-96. PubMed ID: 19813074
[TBL] [Abstract][Full Text] [Related]
29. Pitfalls of reverse transcription quantitative polymerase chain reaction standardization: Volume-related inhibitors of reverse transcription.
Pugniere P; Banzet S; Chaillou T; Mouret C; Peinnequin A
Anal Biochem; 2011 Aug; 415(2):151-7. PubMed ID: 21530480
[TBL] [Abstract][Full Text] [Related]
30. Improving the thermal stability of avian myeloblastosis virus reverse transcriptase α-subunit by site-directed mutagenesis.
Konishi A; Yasukawa K; Inouye K
Biotechnol Lett; 2012 Jul; 34(7):1209-15. PubMed ID: 22426840
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus.
Chen H; McBroom DG; Zhu YQ; Gold L; North TW
Biochemistry; 1996 May; 35(21):6923-30. PubMed ID: 8639644
[TBL] [Abstract][Full Text] [Related]
32. High sensitive one-step RT-PCR using MMLV reverse transcriptase, DNA polymerase with reverse transcriptase activity, and DNA/RNA helicase.
Okano H; Baba M; Yamasaki T; Hidese R; Fujiwara S; Yanagihara I; Ujiiye T; Hayashi T; Kojima K; Takita T; Yasukawa K
Biochem Biophys Res Commun; 2017 May; 487(1):128-133. PubMed ID: 28400277
[No Abstract] [Full Text] [Related]
33. Model of inhibition of Thermus aquaticus polymerase and Moloney murine leukemia virus reverse transcriptase by tea polyphenols (+)-catechin and (-)-epigallocatechin-3-gallate.
Tichopad A; Polster J; Pecen L; Pfaffl MW
J Ethnopharmacol; 2005 Jun; 99(2):221-7. PubMed ID: 15894131
[TBL] [Abstract][Full Text] [Related]
34. Expression of moloney murine leukemia virus reverse transcriptase in a cell-free protein expression system.
Katano Y; Hisayoshi T; Kuze I; Okano H; Ito M; Nishigaki K; Takita T; Yasukawa K
Biotechnol Lett; 2016 Jul; 38(7):1203-11. PubMed ID: 27053084
[TBL] [Abstract][Full Text] [Related]
35. Secondary structure in the 3' UTR of EGF and the choice of reverse transcriptases affect the detection of message diversity by RT-PCR.
Brooks EM; Sheflin LG; Spaulding SW
Biotechniques; 1995 Nov; 19(5):806-12, 814-5. PubMed ID: 8588921
[TBL] [Abstract][Full Text] [Related]
36. Effects of organic solvents on the reverse transcription reaction catalyzed by reverse transcriptases from avian myeloblastosis virus and Moloney murine leukemia virus.
Yasukawa K; Konishi A; Inouye K
Biosci Biotechnol Biochem; 2010; 74(9):1925-30. PubMed ID: 20834159
[TBL] [Abstract][Full Text] [Related]
37. A directed approach to improving the solubility of Moloney murine leukemia virus reverse transcriptase.
Das D; Georgiadis MM
Protein Sci; 2001 Oct; 10(10):1936-41. PubMed ID: 11567084
[TBL] [Abstract][Full Text] [Related]
38. DNA polymerization by the reverse transcriptase of the human L1 retrotransposon on its own template in vitro.
Piskareva O; Schmatchenko V
FEBS Lett; 2006 Jan; 580(2):661-8. PubMed ID: 16412437
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine.
García-Lerma JG; Nidtha S; Heneine W
J Infect Dis; 2001 Aug; 184(4):507-10. PubMed ID: 11471110
[TBL] [Abstract][Full Text] [Related]
40. Trifluoperazine and its metal complexes inhibit the Moloney leukemia virus reverse transcriptase.
Nacsa J; Nagy L; Molnar J; Molnar J
Anticancer Res; 1998; 18(3A):1373-6. PubMed ID: 9673343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
